Medtech company Zimmer Biomet has received approval from the Pharmaceutical and Medical Devices Agency in Japan for the iTaperloc Complete and iG7 Hip System. The iTaperloc Complete and iG7 Hip System ...
Management of newly diagnosed acute myeloid leukemia (AML) in patients deemed unfit for intensive chemotherapy is undergoing rapid transformation toward highly individualized regimens. The combination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback